E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/21/2022 in the Prospect News Bank Loan Daily and Prospect News Investment Grade Daily.

S&P gives Humana notes BBB+

S&P said it assigned its BBB+ debt rating to Humana Inc.'s senior unsecured notes.

Humana plans to use the proceeds for general corporate purposes, including the repayment of a portion of its commercial paper borrowings of $955 million at year-end 2021.

“The debt issuance does not affect our BBB+ issuer credit rating on Humana because the transaction will be leverage neutral. Humana's financial leverage is temporarily elevated (45% as of year-end 2021) due to its debt-funded acquisition of home health provider Kindred at Home (KAH) in 2021. As part of its KAH acquisition, Humana issued $3.5 billion of debt and assumed $2 billion of KAH debt (which it paid off with a $2 billion term loan issuance in October 2021). We expect Humana will reduce its financial leverage to its target of about 35% through debt repayment and earnings growth in 2022,” S&P said in a press release.

The outlook is stable.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.